Globus Medical Inc [NYSE: GMED] plunged by -$5.73 during the normal trading session on while it closed the day at $67.32.
Globus Medical Inc stock has also loss -2.51% of its value over the past 7 days. However, GMED stock has inclined by 5.60% in the 3 months of the year. Over the past six months meanwhile, it has gained 28.72% and gained 26.33% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for GMED stock reached $9.09 billion, with 113.91 million shares outstanding and 111.77 million shares in the current float. Compared to the average trading volume of 919.24K shares, GMED reached a trading volume of 4808531 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Globus Medical Inc [GMED]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GMED shares is $79.15 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GMED stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Globus Medical Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 07, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price from $60 to $80. The new note on the price target was released on May 20, 2024, representing the official price target for Globus Medical Inc stock. Previously, the target price had yet another raise to $60, while BTIG Research analysts kept a Buy rating on GMED stock.
The Average True Range (ATR) for Globus Medical Inc is set at 2.56, with the Price to Sales ratio for GMED stock in the period of the last 12 months amounting to 4.07. The Price to Book ratio for the last quarter was 2.29, with the Price to Cash per share for the same quarter was set at 3.65. Price to Free Cash Flow for GMED in the course of the last twelve months was 56.47 with Quick ratio for the last quarter at 1.45.
GMED stock trade performance evaluation
Globus Medical Inc [GMED] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.51. With this latest performance, GMED shares dropped by -6.50% in over the last four-week period, additionally plugging by 28.72% over the last 6 months – not to mention a rise of 18.02% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GMED stock in for the last two-week period is set at 40.53, with the RSI for the last a single of trading hit 35.82, and the three-weeks RSI is set at 44.61 for Globus Medical Inc [GMED]. The present Moving Average for the last 50 days of trading for this stock 69.25, while it was recorded at 71.60 for the last single week of trading, and 56.87 for the last 200 days.
Globus Medical Inc [GMED]: An insightful look at the core fundamentals
Globus Medical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.45 and a Current Ratio set at 2.42.
Earnings per share (EPS) analysis for Globus Medical Inc [GMED] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GMED. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Globus Medical Inc go to 16.60%.
Globus Medical Inc [GMED]: Institutional Ownership
The top three institutional holders of GMED stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in GMED stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in GMED stock with ownership which is approximately 5.1238%.
